Alan W. Dunton - Sep 12, 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Alan W. Dunton
Stock symbol
CRMD
Transactions as of
Sep 12, 2025
Transactions value $
-$95,800
Form type
4
Date filed
9/16/2025, 09:45 PM
Previous filing
Jun 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DUNTON ALAN W Director C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS /s/ Alan W. Dunton 2025-09-16 0001304773

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise $35.5K +10K +24.84% $3.55 50.3K Sep 12, 2025 Direct
transaction CRMD Common Stock Sale -$131K -10K -19.9% $13.13 40.3K Sep 12, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -10K -33.33% $0.00 20K Sep 12, 2025 Common Stock 10K $3.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $13.00 to $13.25. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.